1. RaySearch launched RayIntelligence v2025, enhancing oncology data analytics. 2. New features allow customized dashboards and deeper integration with existing systems. 3. The update aims to improve clinic operations and patient treatment outcomes. 4. RayIntelligence enables continuous learning from patient journey data. 5. The software is already in use by 1,100 clinics across 47 countries.
RaySearch's release of v2025 reflects innovation and improved data capabilities, which may drive market interest. Historical trends show that technological advancements in healthcare software often correlate with stock appreciation, as seen in similar firms benefiting from updates.
The new software release signifies potential revenue growth and market expansion, reflecting positively on RSLBF's stock performance, supported by its competitive positioning in the oncology analytics space.
The sustained impact of RayIntelligence will unfold as clinics adapt the technology, enhancing treatment outcomes and potentially leading to higher sales and stock appreciation over time.
STOCKHOLM, Sept. 1, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) today announced the release of RayIntelligence®* v2025, a major update to its oncology analytics system designed to transform clinical data into actionable insights. With new tools for building customized dashboards and deeper integration across RaySearch's product portfolio—including RayStation®* and RayCare®*—the system enables clinics to continuously learn from patient journey data and improve treatment outcomes.
In most clinics, large volumes of oncology data are scattered across separate systems, which makes evidence-based improvements slow and fragile. By directly connecting to primary oncology data sources, RayIntelligence helps institutions learn from their own data and adapt their practice, assets, and skills on a continual basis.
With the new customization tools, clinics can create dashboards that reflect their operations and priorities, from plan quality trends and machine utilization to protocol adherence and outcome signals. RayIntelligence v2025 provides a single, comprehensible intelligence layer that equips clinical teams to run a self-improving oncology program, enabling clinics' readiness today and tomorrow.
Johan Löf, founder and CEO, RaySearch, comments: "Our vision for RayIntelligence has always been clear: to transform oncology data into a continuous source of insight. With v2025, we take a significant leap forward. By absorbing and processing data from every stage of the patient journey, the system empowers clinics to refine their treatments and operations over time—building a smarter, more adaptive oncology program for the future."
About RaySearch
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®*. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems. RaySearch's software has been sold to over 1,100 clinics in 47 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003 (STO: RAY B). More information is available at raysearchlabs.com.
About RayIntelligence
Data-driven oncology represents a new era in healthcare. RayIntelligence® is an innovative cloud-based oncology analytics system that gives meaning to data, empowering cancer centers to reach new levels of personalized care through insights based on real-world data.
* Subject to regulatory clearance in some markets.
For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB
Telephone: +46 (0) 8 510 530 00
Carolina Strömlid, Head of Investor Relations, RaySearch Laboratories AB
Telephone: +46 (0) 708 807 173
ir@raysearchlabs.com
Learn more about us on:
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/raysearch-laboratories/r/raysearch-launches-rayintelligence--v2025,c4227416
The following files are available for download:
https://mb.cision.com/Public/1102/4227416/b0d9691cb9674c97.pdf | Press release |
https://news.cision.com/raysearch-laboratories/i/rayintelligence-v2025,c3465551 | RayIntelligence v2025 |
View original content:https://www.prnewswire.com/news-releases/raysearch-launches-rayintelligence-v2025-302542997.html
SOURCE RaySearch Laboratories